{"id":71441,"date":"2025-09-18T10:21:23","date_gmt":"2025-09-18T10:21:23","guid":{"rendered":"https:\/\/kanboapp.com\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/"},"modified":"2025-09-18T10:21:23","modified_gmt":"2025-09-18T10:21:23","slug":"enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector","status":"publish","type":"page","link":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/","title":{"rendered":"Enhancing Risk Visibility: Navigating Critical Challenges and Unleashing New Opportunities for SUSM in the Pharmaceutical Sector"},"content":{"rendered":"<style> @media(min-width:1728px) { .tytulek{font-size:34px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;} .artykul{margin-bottom:120px!important; margin-top:120px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:16px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:8px 8px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:16px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{    flex-basis:35%!important;} .compact-nag{display:none!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 48px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.25px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:19px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 0px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;}  .tekst-para {font-size:17px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:14px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2 { display:block!important; } .pasek-lewy { margin-left:7%!important; } .pasek-prawy {  margin-right:7%!important; } } @media(min-width: 1440px) and (max-width:1727px) { .tytulek{font-size:34px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;} .artykul{margin-bottom:120px!important; margin-top:120px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:16px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:8px 8px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:16px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:35%!important;} .compact-nag{display:none!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 48px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.25px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:19px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 0px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:17px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:14px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2 { display:block!important; } .pasek-lewy {  margin-left:7%!important; } .pasek-prawy {  margin-right:7%!important; } } @media (min-width: 1024px) and (max-width:1439px) { .tytulek{font-size:34px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;} .artykul{margin-bottom:120px!important; margin-top:120px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:16px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:8px 8px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:16px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:35%!important;} .compact-nag{display:none!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 32px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.25px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:19px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 0px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:17px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:14px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2{ display:block!important; } .pasek-lewy {  margin-left:7%!important; } .pasek-prawy {  margin-right:7%!important; } } @media (min-width: 782px) and (max-width:1023px) { .tytulek{font-size:25px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;}  .artykul{margin-bottom:80px!important; margin-top:30px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:14px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:10px 4px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:14px!important; line-height: 150% !important;}  .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:60%!important;} .compact-nag{display:block!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 32px!important; font-size:19px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.19px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:16px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 32px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:12px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:13px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2 { display:none!important; } .pasek-lewy { margin-left:32px!important; } .pasek-prawy {margin-right:32px!important; } } @media (max-width:781px) {  .tytulek{font-size:25px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 16px!important; margin-right: 16px!important;}  .artykul{margin-bottom:80px!important; margin-top:30px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:14px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:10px 4px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:14px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:100%!important;} .compact-nag{display:block!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 48px!important; font-size:19px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.19px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:16px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 32px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:12px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:13px!important;} .prawy-link a{font-size:16px!important;} .spis { display:none!important; } .spis2 { display:none!important; } .pasek-lewy { margin-left:16px!important; } .pasek-prawy {margin-right:16px!important; } } .prawy-link a:hover { color:#145A92!important} .banner { margin-top:80px; margin-bottom:80px; } .jazda-nowsza { position:sticky!important; top: 120px; overflow: auto; max-height: 85vh; }  .fobrazek { margin-bottom: -40px!important; } .sekcja5-przycisk a:hover { background: linear-gradient(0deg, rgba(0, 0, 0, 0.15), rgba(0, 0, 0, 0.15)), #ED4B9E!important; }  .sekcja5-przycisk a:focus { background: linear-gradient(0deg, rgba(0, 0, 0, 0.15), rgba(0, 0, 0, 0.15)), #ED4B9E!important; } .vlp-layout-blogs .vlp-block-0 {font-weight: 600!important; } .prawy-tytul-pulpit {font-size:19px!important;} .ct-container-narrow {max-width: 1200px!important;}  :nth-last-child(1 of .tekst-para) {margin-bottom: 0px!important;} <\/style><script> function lewemenu(zm) { var elements = document.getElementsByClassName(\"menu-lewe\"); var i,link1,link2; for (i = 0; i < elements.length; i++) {    link1 = elements[i].getElementsByTagName(\"a\");     link1[0].style.fontWeight = \"600\";     link1[0].style.backgroundColor= \"#FAFAFA\"; } link2 = elements[zm].getElementsByTagName(\"a\"); link2[0].style.fontWeight = \"600\"; link2[0].style.backgroundColor= \"#E9F4FE\"; } <\/script><div class=\"wp-block-getwid-section alignfull alignfull getwid-margin-top-none getwid-margin-bottom-none getwid-section-content-full-width\"><div class=\"wp-block-getwid-section__wrapper getwid-padding-top-none getwid-padding-bottom-none getwid-padding-left-none getwid-padding-right-none getwid-margin-left-none getwid-margin-right-none\" style=\"min-height:100vh\"><div class=\"wp-block-getwid-section__inner-wrapper\"><div class=\"wp-block-getwid-section__background-holder\"><div class=\"wp-block-getwid-section__background has-background\" style=\"background-color:#fafafa\"><\/div><div class=\"wp-block-getwid-section__foreground\"><\/div><\/div><div class=\"wp-block-getwid-section__content\"><div class=\"wp-block-getwid-section__inner-content\"><div class=\"wp-block-columns alignfull artykul is-layout-flex wp-container-core-columns-is-layout-f96e3eba wp-block-columns-is-layout-flex\" style=\"margin-top:0px;margin-bottom:0px\"><div class=\"wp-block-column pasek-lewy spis jazda-nowsza is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-995f960e wp-block-columns-is-layout-flex\"><div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><p class=\"menu-lewe wp-elements-64bbeaf0fde57b05b3764fc03eb15d1f wp-block-paragraph\" onclick=\"lewemenu(0)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/#section1\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/#section1\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Why change?<\/a><\/p><p class=\"menu-lewe wp-elements-3f347277849ccf3da5db5864fb66ace0 wp-block-paragraph\" onclick=\"lewemenu(1)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/#section2\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/#section2\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Background \/ Definition<\/a><\/p><p class=\"menu-lewe wp-elements-a8d63f43d9e5f2f8840043cebec0e6b9 wp-block-paragraph\" onclick=\"lewemenu(2)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/#section3\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/#section3\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Case-Style Mini-Examples<\/a><\/p><p class=\"menu-lewe wp-elements-9dfb57ae201a47a572510b916f6611dc wp-block-paragraph\" onclick=\"lewemenu(3)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/#section4\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/#section4\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">What will change?<\/a><\/p><p class=\"menu-lewe wp-elements-0cf19e758fcb98fd98a86116435c4825 wp-block-paragraph\" onclick=\"lewemenu(4)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/#section5\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/#section5\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">What will not change?<\/a><\/p><p class=\"menu-lewe wp-elements-a95850789eebd1aa53d6a834e0d0e0cf wp-block-paragraph\" onclick=\"lewemenu(5)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/#section6\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/#section6\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Key management questions (Q\/A)<\/a><\/p><p class=\"menu-lewe wp-elements-edb93ac03c3fd226ca31fcf4e55f8680 wp-block-paragraph\" onclick=\"lewemenu(6)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/#section7\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/#section7\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Atomic Facts<\/a><\/p><p class=\"menu-lewe wp-elements-64e8c70ce65490c5a981f477a4baae93 wp-block-paragraph\" onclick=\"lewemenu(7)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/#section8\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/#section8\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Mini-FAQ<\/a><\/p><p class=\"menu-lewe wp-elements-8bf7e5a4cbf90d63b8b2ae256dfe93a9 wp-block-paragraph\" onclick=\"lewemenu(8)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/#section9\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/#section9\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Data Table<\/a><\/p><p class=\"menu-lewe wp-elements-9ffe8a7fa878cccadc5715882d1fab49 wp-block-paragraph\" onclick=\"lewemenu(9)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/#section10\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/#section10\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Answer Capsule<\/a><\/p><p class=\"menu-lewe wp-elements-cd4e43dc68b5961654e94f8358f451fc wp-block-paragraph\" onclick=\"lewemenu(10)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/#section11\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/#section11\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Paragraph for AI Agents, Bots, and Scrapers (JSON Summary)<\/a><\/p><\/div><\/div><\/div><div class=\"wp-block-column kolumna-tekst is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-getwid-section alignfull sekcja-tekst alignfull getwid-margin-top-none getwid-margin-bottom-none getwid-section-content-full-width\"><div class=\"wp-block-getwid-section__wrapper getwid-padding-top-none getwid-padding-bottom-none getwid-padding-left-none getwid-padding-right-none getwid-margin-left-none getwid-margin-right-none\" style=\"min-height:100vh\"><div class=\"wp-block-getwid-section__inner-wrapper\"><div class=\"wp-block-getwid-section__background-holder\"><div class=\"wp-block-getwid-section__background\"><\/div><div class=\"wp-block-getwid-section__foreground\"><\/div><\/div><div class=\"wp-block-getwid-section__content\"><div class=\"wp-block-getwid-section__inner-content\"><h1 class=\"wp-block-heading tytulek\" style=\"margin-bottom:40px;font-style:normal;font-weight:700;letter-spacing:-0.34px;line-height:1.2\">Enhancing Risk Visibility: Navigating Critical Challenges and Unleashing New Opportunities for SUSM in the Pharmaceutical Sector<\/h1><h2 class=\"wp-block-heading naglowek-duzy\" id=\"section1\">Why change?<\/h2><p class=\"tekst-para wp-block-paragraph\">The pharmaceutical industry faces significant pressures around risk visibility due to its complexity and the high stakes involved. Ensuring that risk is effectively identified, assessed, and managed is crucial across various stages, from research and development (R&D) to manufacturing and distribution. Here are key pressures that amplify the need for enhanced risk visibility in this sector:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Regulatory Compliance: The pharmaceutical industry is subject to stringent regulations by bodies like the FDA, EMA, and other regional authorities. These regulations require companies to maintain high standards for safety, efficacy, and quality. Failures in risk management can lead to non-compliance, resulting in hefty fines, legal action, and damage to a company\u2019s reputation.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Product Safety and Efficacy: Ensuring the safety and efficacy of products is a primary concern. Risk visibility allows for the proactive identification of potential safety issues or efficacy failures, which could lead to costly recalls or lawsuits if not addressed promptly.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Supply Chain Complexity: Pharmaceuticals often rely on global supply chains, making them vulnerable to disruptions. Risk visibility is vital for anticipating and mitigating risks related to supply chain reliability and resilience.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Litigation Risks: Given the potential impact of pharmaceuticals on health, companies are at high risk of litigation due to adverse effects. Clear risk visibility helps organizations manage and mitigate grievances effectively, reducing the likelihood of prolonged and expensive legal battles.<\/p><p class=\"tekst-para wp-block-paragraph\">5. Innovation and Competition: As companies race to develop new drugs, they face pressure to innovate while maintaining rigorous standards of safety and quality. Proper risk management ensures that potential issues do not derail development processes, facilitating faster time-to-market for new treatments.<\/p><p class=\"tekst-para wp-block-paragraph\">Quantifying the Risk of Inaction:<\/p><p class=\"tekst-para wp-block-paragraph\">The costs associated with inadequate risk visibility can be significant and include:<\/p><p class=\"tekst-para wp-block-paragraph\">- Financial Losses: Penalties for non-compliance can reach into the billions, while costs for recalling products and handling lawsuits can further strain financial resources.<\/p><p class=\"tekst-para wp-block-paragraph\">  <\/p><p class=\"tekst-para wp-block-paragraph\">- Market Position and Share: A major risk event can erode consumer and investor trust, leading to loss of market share as competitors capitalize on the company\u2019s vulnerabilities.<\/p><p class=\"tekst-para wp-block-paragraph\">  <\/p><p class=\"tekst-para wp-block-paragraph\">- Operational Disruptions: Unforeseen risks, such as a raw material shortage in the supply chain, can stall production, leading to significant delays in product availability.<\/p><p class=\"tekst-para wp-block-paragraph\">  <\/p><p class=\"tekst-para wp-block-paragraph\">- R&D Interruptions: Lack of risk foresight may lead to R&D setbacks, impacting the pipeline and future revenue streams.<\/p><p class=\"tekst-para wp-block-paragraph\">Implementing a robust risk visibility and management framework is crucial, regardless of the software system used. While specific tools, such as KanBo, support better organization and visibility of tasks and risks by allowing teams to track and collaborate in real-time, it is essential that organizations maintain a comprehensive, adaptable approach that transcends specific software capabilities and integrates well with organizational processes.<\/p><p class=\"tekst-para wp-block-paragraph\">Overall, the pharmaceutical industry must prioritize risk visibility to mitigate existing pressures and ensure both regulatory compliance and product safety, while maintaining operational efficiency and sustaining innovation.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section2\">Background \/ Definition<\/h3><p class=\"tekst-para wp-block-paragraph\"> Risk Visibility for a CSU Start-Up Strategy Manager (SUSM) in Pharmaceutical<\/p><p class=\"tekst-para wp-block-paragraph\">In the dynamic world of pharmaceutical start-ups, a CSU Start-Up Strategy Manager (SUSM) must navigate a complex landscape filled with regulatory requirements, technological advancements, and competitive pressures. Effective risk visibility is crucial to manage these challenges proactively and ensure the success of the start-up. Risk visibility in this context refers to the ability to identify, monitor, and manage potential obstacles and threats that could hinder project objectives or timelines.<\/p><p class=\"tekst-para wp-block-paragraph\"> Key Terms:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Card Blocker: <\/p><p class=\"tekst-para wp-block-paragraph\">   - An issue or obstacle impeding the progress of a task. <\/p><p class=\"tekst-para wp-block-paragraph\">   - Types include:<\/p><p class=\"tekst-para wp-block-paragraph\">     - Local Blockers: Specific to a single task.<\/p><p class=\"tekst-para wp-block-paragraph\">     - Global Blockers: Affecting multiple tasks or the entire project.<\/p><p class=\"tekst-para wp-block-paragraph\">     - On-Demand Blockers: Arising situationally, based on resource or information availability.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Date Conflict: <\/p><p class=\"tekst-para wp-block-paragraph\">   - Occurs when there is an inconsistency or overlap in the start or due dates between related tasks.<\/p><p class=\"tekst-para wp-block-paragraph\">   - Can cause confusion in task prioritization and resource allocation.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Card Relation: <\/p><p class=\"tekst-para wp-block-paragraph\">   - Represents dependencies between tasks, categorizing them into:<\/p><p class=\"tekst-para wp-block-paragraph\">     - Parent and Child: Hierarchical task breakdown.<\/p><p class=\"tekst-para wp-block-paragraph\">     - Next and Previous: Sequential task order.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Notification: <\/p><p class=\"tekst-para wp-block-paragraph\">   - Alerts that inform users about significant updates or changes in tasks, such as status changes or new comments.<\/p><p class=\"tekst-para wp-block-paragraph\"> How KanBo Reframes Risk with Enhanced Visibility<\/p><p class=\"tekst-para wp-block-paragraph\">KanBo provides a comprehensive platform to address the challenges of risk visibility through structured and intuitive tools like visible blockers, mapped dependencies, and proactive notifications.<\/p><p class=\"tekst-para wp-block-paragraph\">1. Visible Blockers:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Explicit Identification: KanBo allows SUSMs to create multiple card blockers, each categorized to detail the precise reason for a task's halt. This transparency helps in swiftly resolving issues by tackling the root cause.<\/p><p class=\"tekst-para wp-block-paragraph\">   - Categorization: By distinguishing between local, global, and on-demand blockers, SUSMs can strategize effectively to allocate resources where needed most.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Mapped Dependencies:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Clarified Relations: Through card relations, tasks are mapped with clear dependencies, highlighting the sequence (\u201cnext and previous\u201d) and hierarchy (\u201cparent and child\u201d) of operations. This ensures clear workflow progression and aids in anticipating bottlenecks.<\/p><p class=\"tekst-para wp-block-paragraph\">   - Date Conflict Resolution: By visibly mapping date dependencies, it becomes easier to identify and address conflicts proactively, maintaining the integrity of project timelines.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Proactive Notifications:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Real-Time Alerts: Notifications keep SUSMs and their teams updated with real-time changes, ensuring immediate action can be taken when high-impact risks, such as delays or requirement changes, surface.<\/p><p class=\"tekst-para wp-block-paragraph\">   - Customizability: By tailoring notifications, teams receive only the most relevant updates, reducing information overload and enhancing focus on critical areas.<\/p><p class=\"tekst-para wp-block-paragraph\"> Conclusion<\/p><p class=\"tekst-para wp-block-paragraph\">For a CSU Start-Up Strategy Manager in the pharmaceutical sector, KanBo's approach to risk visibility through visible blockers, mapped dependencies, and notifications transforms potential project delivery and performance challenges into manageable opportunities for improvement. This empowers managers to stay ahead of risks, ensuring that their strategies align with project goals and timelines efficiently.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section3\">Case-Style Mini-Examples<\/h3><p class=\"tekst-para wp-block-paragraph\"> Case-Study: Enhancing Risk Visibility with KanBo for a CSU Start-Up Strategy Manager (SUSM) in Pharmaceuticals<\/p><p class=\"tekst-para wp-block-paragraph\"> Setting the Scene<\/p><p class=\"tekst-para wp-block-paragraph\">In the bustling environment of a pharmaceutical start-up, a CSU Start-Up Strategy Manager (SUSM), Alex, faces critical challenges in managing risk across multiple concurrent projects. These projects encompass various stages from experimental R&D trials to regulatory submissions. Traditional methods of managing tasks using spreadsheets and email have resulted in inefficiencies, delays, and heightened risks, severely impacting timelines and compliance with regulatory requirements.<\/p><p class=\"tekst-para wp-block-paragraph\"> Challenges with Traditional Methods<\/p><p class=\"tekst-para wp-block-paragraph\">1. Spreadsheet Management:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Task lists are maintained in spreadsheets, leading to difficulties in tracking task status, dependencies, and updates.<\/p><p class=\"tekst-para wp-block-paragraph\">   - Lack of real-time collaboration results in frequent bottlenecks, as communication lags lead to delays in resolving task impediments.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Email Overload:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Important updates and changes often get buried under an avalanche of emails, causing critical risks to go unnoticed or unaddressed.<\/p><p class=\"tekst-para wp-block-paragraph\">   - Reliance on manual follow-ups for task milestones and deadlines results in inefficiencies and increased chances of error.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Risk Visibility Gaps:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Identifying and managing task blockers is cumbersome, often identified only after significant delays.<\/p><p class=\"tekst-para wp-block-paragraph\">   - Due date conflicts and dependencies are overlooked, causing scheduling conflicts and resource misallocation.<\/p><p class=\"tekst-para wp-block-paragraph\"> Transformation Using KanBo<\/p><p class=\"tekst-para wp-block-paragraph\">Alex switches to KanBo to address these challenges, leveraging its unique features to enhance risk visibility and management:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Card Blocker Feature:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Alex uses Local and Global Blockers to explicitly mark tasks halting due to specific impediments, such as awaiting regulatory approval or data from suppliers.<\/p><p class=\"tekst-para wp-block-paragraph\">   - This visibility allows Alex to prioritize resolving these blockers with targeted strategies, improving workflow continuity.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Resolving Date Conflicts and Managing Dependencies:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Through Card Relation features, tasks are mapped with clear dependencies using 'Parent and Child' and 'Next and Previous' relations. This visual representation aids in sequential task execution and identifies potential scheduling conflicts proactively.<\/p><p class=\"tekst-para wp-block-paragraph\">   - Alex addresses date conflicts by adjusting timelines based on real-time insights from mapped dependencies, ensuring tasks are prioritized accurately without overlaps.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Proactive Notifications and Updates:<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo\u2019s Notification System provides real-time alerts on task status changes, comments, and deadline shifts, enabling Alex to act swiftly upon any emerging risks.<\/p><p class=\"tekst-para wp-block-paragraph\">   - Customizable notifications ensure Alex and the team stay attuned to crucial updates without being overwhelmed by irrelevant information.<\/p><p class=\"tekst-para wp-block-paragraph\"> Impact on Project and Organizational Success<\/p><p class=\"tekst-para wp-block-paragraph\">- Improved Efficiency: With KanBo, task management becomes seamless, minimizing delays and ensuring timely project completion.<\/p><p class=\"tekst-para wp-block-paragraph\">- Enhanced Risk Management: Visible task blockers, clear dependencies, and prompt alerts cultivate proactive risk identification and resolution.<\/p><p class=\"tekst-para wp-block-paragraph\">- Regulatory Compliance: By resolving blockers and date conflicts efficiently, projects align better with regulatory timelines, reducing compliance risks.<\/p><p class=\"tekst-para wp-block-paragraph\">- Streamlined Communication: Real-time updates and visual task mapping aid in clear communication, reducing reliance on email chains and improving team collaboration.<\/p><p class=\"tekst-para wp-block-paragraph\"> Conclusion<\/p><p class=\"tekst-para wp-block-paragraph\">For Alex, using KanBo not only mitigates the risks associated with traditional task management methods but also transforms risk visibility into a structured, real-time, and collaborative process. This ensures that the CSU's projects meet strategic goals efficiently while maintaining compliance with the rigorous standards of the pharmaceutical industry. The improved risk visibility and management result in sustained innovation, competitive advantage, and ultimately, contribute to the start-up's growth and success in the market.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section4\">What will change?<\/h3><p class=\"tekst-para wp-block-paragraph\">In the fast-paced pharmaceutical start-up environment, traditional tools and outdated methodologies often fall short in providing the necessary risk visibility and agility needed for a CSU Start-Up Strategy Manager (SUSM). KanBo modernizes and enhances these processes significantly:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Core Concepts & Navigation:<\/p><p class=\"tekst-para wp-block-paragraph\">    - Old School: Utilizing spreadsheets and manual tracking for managing project hierarchies and tasks.<\/p><p class=\"tekst-para wp-block-paragraph\">    - KanBo Replacement: KanBo\u2019s structured hierarchy of workspaces, spaces, and cards revolutionizes task organization and navigation. Spaces act as dynamic collections of tasks, visible in various formats, offering more clarity and context than static lists.<\/p><p class=\"tekst-para wp-block-paragraph\">2. User Management:<\/p><p class=\"tekst-para wp-block-paragraph\">    - Old School: Email chains and shared drives lack structured role-based access, leading to permission confusion and inefficiencies.<\/p><p class=\"tekst-para wp-block-paragraph\">    - KanBo Replacement: Clarifies roles and permissions with defined user access levels and tracks activities with an activity stream, enhancing accountability and security.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Workspace and Space Management:<\/p><p class=\"tekst-para wp-block-paragraph\">    - Old School: Static project folders and limited collaboration tools hamper dynamic project handling and external collaboration.<\/p><p class=\"tekst-para wp-block-paragraph\">    - KanBo Replacement: Flexible workspace and space types allow tailored privacy and collaboration settings, facilitating both internal and external stakeholder involvement smoothly.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Card Management:<\/p><p class=\"tekst-para wp-block-paragraph\">    - Old School: Task lists fail to depict dependencies and blocker status, leading to overlooked bottlenecks.<\/p><p class=\"tekst-para wp-block-paragraph\">    - KanBo Replacement: KanBo\u2019s cards system with status roles, card blockers, and relations (parent-child structures) provides enhanced visibility into task progression and dependencies, initiating proactive adjustments.<\/p><p class=\"tekst-para wp-block-paragraph\">5. Document Management:<\/p><p class=\"tekst-para wp-block-paragraph\">    - Old School: Fragmented document storage and version control issues.<\/p><p class=\"tekst-para wp-block-paragraph\">    - KanBo Replacement: Centralized document handling linking external corporate libraries ensures document consistency and accessibility across projects.<\/p><p class=\"tekst-para wp-block-paragraph\">6. Searching and Filtering:<\/p><p class=\"tekst-para wp-block-paragraph\">    - Old School: Sifting through emails and documents manually to find information.<\/p><p class=\"tekst-para wp-block-paragraph\">    - KanBo Replacement: Advanced search and filter functionalities allow swift access to relevant information and insights across the entire platform.<\/p><p class=\"tekst-para wp-block-paragraph\">7. Reporting & Visualization:<\/p><p class=\"tekst-para wp-block-paragraph\">    - Old School: Basic Gantt charts on paper or in separate applications that may not reflect real-time data.<\/p><p class=\"tekst-para wp-block-paragraph\">    - KanBo Replacement: Integrated and interactive views such as Gantt charts, Time Charts, and Forecasts provide data-driven insights into project timelines and potential impediments, facilitating informed decision-making.<\/p><p class=\"tekst-para wp-block-paragraph\">By transitioning from traditional tools to KanBo, a CSU Start-Up Strategy Manager in the pharmaceutical industry gains enhanced risk visibility, allowing for better management of project timelines and strategic objectives. This shift reduces the likelihood of unforeseen obstacles and supports proactive strategy adjustments for improved project outcomes.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section5\">What will not change?<\/h3><p class=\"tekst-para wp-block-paragraph\">In the role of CSU Start-Up Strategy Manager (SUSM) in the Pharmaceutical industry, despite evolving technologies amplifying our capabilities, certain constants remain unchanged: Leadership judgment, strategy ownership, and accountability are fundamentally human tasks. A human-first approach is paramount, ensuring risk visibility and management remain aligned with human insight, ethical considerations, and strategic understanding. Technology can enhance processes and provide data-driven insights, but the final responsibility and decision-making rest with the human leaders who interpret and act on this information. These constants serve as the pillars of effective risk visibility and management within any strategy framework.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section6\">Key management questions (Q\/A)<\/h3><p class=\"tekst-para wp-block-paragraph\">Who did what and when? \u2192 KanBo logs actions taken by team members, such as creating, updating, or completing tasks, providing a timeline of user activities.<\/p><p class=\"tekst-para wp-block-paragraph\">What threatens the critical path? \u2192 Potential threats to the critical path include unresolved global blockers, unresolved date conflicts, and key tasks not reaching completion according to the timeline.<\/p><p class=\"tekst-para wp-block-paragraph\">Where are bottlenecks? \u2192 Bottlenecks occur where global blockers persist or in sections with complex card relations, causing task progression delays.<\/p><p class=\"tekst-para wp-block-paragraph\">Which tasks are overdue and why? \u2192 Overdue tasks are identified through missed due dates, potentially due to unresolved local blockers, resource constraints, or mismanaged dependencies.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section7\">Atomic Facts<\/h3><p class=\"tekst-para wp-block-paragraph\">1. Regulatory Compliance Pressure: Pharmaceutical startups must navigate stringent regulations from bodies like the FDA and EMA, where non-compliance can result in fines and legal actions, underscoring the critical need for precise risk visibility. <\/p><p class=\"tekst-para wp-block-paragraph\">2. Financial Impact of Risk Management: Effective risk visibility helps avoid substantial financial losses from non-compliance penalties and recalls, which can reach billions, emphasizing the importance of proactive risk management.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Supply Chain Vulnerability: The global nature of pharmaceutical supply chains renders them susceptible to disruptions. Enhanced risk visibility ensures timely identification and mitigation of risks, maintaining operational continuity.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Litigation Risk Management: The high potential of litigation due to adverse drug effects makes clear risk visibility essential, facilitating effective grievance management and reducing legal and financial repercussions.<\/p><p class=\"tekst-para wp-block-paragraph\">5. Competitive Innovation Pressure: Startups need to innovate swiftly without compromising safety. Robust risk management processes are vital for identifying and addressing potential issues, supporting faster drug development and market entry.<\/p><p class=\"tekst-para wp-block-paragraph\">6. R&D Pipeline Impact: Ineffective risk visibility may lead to R&D delays, affecting the product pipeline and future revenue. A robust risk management framework can mitigate such impacts, ensuring project milestones are met.<\/p><p class=\"tekst-para wp-block-paragraph\">7. Date Conflict Mitigation: Risk visibility tools like KanBo help address conflicts arising from inconsistent task dates, ensuring better prioritization and resource allocation to maintain project timelines and efficiency. <\/p><p class=\"tekst-para wp-block-paragraph\">8. Enhanced Communication with Notifications: Real-time notifications about task changes provide immediate insights for SUSMs, allowing them to take timely actions that could avert high-impact risks and maintain project momentum.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section8\">Mini-FAQ<\/h3><p class=\"tekst-para wp-block-paragraph\">1. What is risk visibility in the context of pharmaceutical start-ups?<\/p><p class=\"tekst-para wp-block-paragraph\">   - Risk visibility refers to the ability to identify, monitor, and manage potential obstacles and threats that could hinder project objectives or timelines within a pharmaceutical start-up.<\/p><p class=\"tekst-para wp-block-paragraph\">2. How does KanBo help in identifying potential risks within projects?<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo enhances risk visibility by allowing users to utilize visible blockers, mapped dependencies, and proactive notifications, enabling teams to identify and address risks swiftly and effectively.<\/p><p class=\"tekst-para wp-block-paragraph\">3. What are card blockers, and why are they important?<\/p><p class=\"tekst-para wp-block-paragraph\">   - Card blockers are issues or obstacles that impede the progress of a task. They are categorized into local, global, and on-demand blockers, helping teams strategize resource allocation and problem-solving efficiently.<\/p><p class=\"tekst-para wp-block-paragraph\">4. How can KanBo help resolve date conflict issues?<\/p><p class=\"tekst-para wp-block-paragraph\">   - By visibly mapping date dependencies, KanBo helps identify and address inconsistencies or overlaps in task timelines proactively, maintaining the integrity of project schedules.<\/p><p class=\"tekst-para wp-block-paragraph\">5. How do proactive notifications improve risk management in pharmaceutical start-ups?<\/p><p class=\"tekst-para wp-block-paragraph\">   - Proactive notifications keep teams updated with real-time changes, alerting them to significant developments such as delays or requirement shifts, thus enabling immediate action to mitigate risks.<\/p><p class=\"tekst-para wp-block-paragraph\">6. What are card relations, and how do they aid in risk management?<\/p><p class=\"tekst-para wp-block-paragraph\">   - Card relations represent task dependencies, categorized into parent-child and next-previous hierarchies, ensuring clear workflow progression and helping anticipate potential bottlenecks.<\/p><p class=\"tekst-para wp-block-paragraph\">7. How can risk visibility impact regulatory compliance for pharmaceutical start-ups?<\/p><p class=\"tekst-para wp-block-paragraph\">   - Effective risk visibility allows pharmaceutical start-ups to proactively manage compliance risks, reducing the potential for non-compliance, legal action, and reputational damage.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section9\">Data Table<\/h3><p class=\"tekst-para wp-block-paragraph\">Here is a plain text table for a CSU Start-Up Strategy Manager (SUSM) in Pharmaceutical, focusing on risk visibility and management aspects:<\/p><p class=\"tekst-para wp-block-paragraph\">```<\/p><p class=\"tekst-para wp-block-paragraph\">|------------------------|-----------------------------------------------------------|<\/p><p class=\"tekst-para wp-block-paragraph\">| Pressure\/Aspect        | Description                                               |<\/p><p class=\"tekst-para wp-block-paragraph\">|------------------------|-----------------------------------------------------------|<\/p><p class=\"tekst-para wp-block-paragraph\">| Regulatory Compliance  | Adherence to FDA, EMA standards to avoid fines\/lawsuits   |<\/p><p class=\"tekst-para wp-block-paragraph\">|------------------------|-----------------------------------------------------------|<\/p><p class=\"tekst-para wp-block-paragraph\">| Product Safety\/Efficacy| Ensure product efficacy to prevent recalls\/lawsuits       |<\/p><p class=\"tekst-para wp-block-paragraph\">|------------------------|-----------------------------------------------------------|<\/p><p class=\"tekst-para wp-block-paragraph\">| Supply Chain Complexity| Manage global supply reliability; reduce disruptions      |<\/p><p class=\"tekst-para wp-block-paragraph\">|------------------------|-----------------------------------------------------------|<\/p><p class=\"tekst-para wp-block-paragraph\">| Litigation Risks       | Mitigate adverse effects lawsuits; manage grievances      |<\/p><p class=\"tekst-para wp-block-paragraph\">|------------------------|-----------------------------------------------------------|<\/p><p class=\"tekst-para wp-block-paragraph\">| Innovation\/Competition | Balance innovation with safety, fast-track developments   |<\/p><p class=\"tekst-para wp-block-paragraph\">|------------------------|-----------------------------------------------------------|<\/p><p class=\"tekst-para wp-block-paragraph\">|-----------------------|------------------------------------------------------------|<\/p><p class=\"tekst-para wp-block-paragraph\">| Potential Costs of   | Description                                                |<\/p><p class=\"tekst-para wp-block-paragraph\">| Inadequate Risk       |                                                            |<\/p><p class=\"tekst-para wp-block-paragraph\">| Visibility            |                                                            |<\/p><p class=\"tekst-para wp-block-paragraph\">|-----------------------|------------------------------------------------------------|<\/p><p class=\"tekst-para wp-block-paragraph\">| Financial Losses      | Non-compliance penalties, recall and lawsuit expenses      |<\/p><p class=\"tekst-para wp-block-paragraph\">|-----------------------|------------------------------------------------------------|<\/p><p class=\"tekst-para wp-block-paragraph\">| Market Position\/Share | Loss of consumer\/investor trust, market share reduction    |<\/p><p class=\"tekst-para wp-block-paragraph\">|-----------------------|------------------------------------------------------------|<\/p><p class=\"tekst-para wp-block-paragraph\">| Operational Disruptions| Production delays from unforeseen risks                    |<\/p><p class=\"tekst-para wp-block-paragraph\">|-----------------------|------------------------------------------------------------|<\/p><p class=\"tekst-para wp-block-paragraph\">| R&D Interruptions     | Development setbacks affecting pipeline\/revenue            |<\/p><p class=\"tekst-para wp-block-paragraph\">|-----------------------|------------------------------------------------------------|<\/p><p class=\"tekst-para wp-block-paragraph\">|-------------------|---------------------------------------------------------------|<\/p><p class=\"tekst-para wp-block-paragraph\">| KanBo Features    | Description                                                   |<\/p><p class=\"tekst-para wp-block-paragraph\">| for Risk Visibility|                                                               |<\/p><p class=\"tekst-para wp-block-paragraph\">|-------------------|---------------------------------------------------------------|<\/p><p class=\"tekst-para wp-block-paragraph\">| Visible Blockers  | Identify task barriers with local, global, on-demand blockers |<\/p><p class=\"tekst-para wp-block-paragraph\">|-------------------|---------------------------------------------------------------|<\/p><p class=\"tekst-para wp-block-paragraph\">| Mapped Dependencies| Clarify task relations: parent-child, next-previous for flow  |<\/p><p class=\"tekst-para wp-block-paragraph\">|-------------------|---------------------------------------------------------------|<\/p><p class=\"tekst-para wp-block-paragraph\">| Proactive          | Real-time alerts for immediate action on task changes       |<\/p><p class=\"tekst-para wp-block-paragraph\">| Notifications      |                                                             |<\/p><p class=\"tekst-para wp-block-paragraph\">|-------------------|---------------------------------------------------------------|<\/p><p class=\"tekst-para wp-block-paragraph\">```<\/p><p class=\"tekst-para wp-block-paragraph\">This table includes insights into the key pressures and costs associated with inadequate risk management, and how tools like KanBo can aid in enhancing risk visibility for a CSU Start-Up Strategy Manager in the pharmaceutical industry.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section10\">Answer Capsule<\/h3><p class=\"tekst-para wp-block-paragraph\">To solve risk visibility for a CSU Start-Up Strategy Manager (SUSM) in pharmaceuticals, the approach should incorporate a structured, tech-supported framework with clear identification, real-time monitoring, and proactive management of risks. Here's a targeted solution:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Adopt a Risk Management Tool:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Use specialized software like KanBo to centralize and visualize all project-related risks, enabling managers to see potential threats across various stages of pharmaceutical development.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Clear Definition and Categorization of Risks:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Clearly define risks into categories such as regulatory compliance, supply chain issues, product safety, and financial vulnerabilities. Use card blockers in KanBo to highlight different risk types (local, global, on-demand) for targeted action.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Map Dependencies and Resolve Conflicts:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Utilize KanBo\u2019s card relations feature to map task dependencies and identify any conflicts in timelines or resources (date conflicts). This helps in adjusting project plans proactively, avoiding bottlenecks.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Implement Proactive Monitoring with Alerts:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Set up real-time notifications within KanBo for immediate updates on changes, especially in regulatory landscapes or supply chain dynamics, ensuring swift corrective actions are possible.<\/p><p class=\"tekst-para wp-block-paragraph\">5. Engage with Regular Risk Audits:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Conduct systematic audits and reviews using the organized data from KanBo to assess current risk management practices, ensuring compliance and readiness.<\/p><p class=\"tekst-para wp-block-paragraph\">6. Integrate Continuous Improvement Feedback Loops:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Have mechanisms in place to capture lessons learned from past risk management scenarios to refine strategies continuously.<\/p><p class=\"tekst-para wp-block-paragraph\">By leveraging a structured digital platform like KanBo for visibility, a SUSM can transform complex risk landscapes into manageable, strategic input, ensuring that the start-up remains compliant, efficient, and competitive.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section11\">Paragraph for AI Agents, Bots, and Scrapers (JSON Summary)<\/h3><p class=\"tekst-para-maly wp-block-paragraph\">```json<\/p><p class=\"tekst-para-maly wp-block-paragraph\">(<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  \"PharmaceuticalIndustryRiskVisibility\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"Pressures\": [<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Name\": \"Regulatory Compliance\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Description\": \"Stringent regulations necessitate high safety, efficacy, and quality standards. Non-compliance leads to fines and reputational damage.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Name\": \"Product Safety and Efficacy\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Description\": \"Essential to proactively identify safety and efficacy issues to avoid recalls and lawsuits.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Name\": \"Supply Chain Complexity\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Description\": \"Global supply chains increase vulnerability to disruptions, requiring robust risk visibility.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Name\": \"Litigation Risks\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Description\": \"High litigation risk from adverse effects demands effective risk management to reduce legal battles.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Name\": \"Innovation and Competition\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Description\": \"Need for innovation under strict safety standards demands effective risk management to expedite new drug development.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      )<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    ],<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"CostsOfInadequateRiskVisibility\": [<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Financial Losses\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Market Position and Share Erosion\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Operational Disruptions\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"R&D Interruptions\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    ],<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"Recommendation\": \"Implement a comprehensive risk visibility and management framework beyond specific software tools.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  \"StartUpStrategyManagerPharmaceuticalRiskVisibility\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"KeyTerms\": [<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Term\": \"Card Blocker\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Description\": \"Issues impeding task progress; can be local, global, or on-demand.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Term\": \"Date Conflict\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Description\": \"Overlaps in task dates causing prioritization and resource challenges.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Term\": \"Card Relation\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Description\": \"Task dependencies categorized in hierarchy or sequence.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Term\": \"Notification\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Description\": \"Updates on task status or changes.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      )<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    ],<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"KanBoFeatures\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"VisibleBlockers\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Description\": \"Enables explicit identification and categorization of blockers.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"MappedDependencies\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Description\": \"Clarifies task relations and aids in resolving date conflicts.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"ProactiveNotifications\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Description\": \"Real-time, customizable alerts to manage risks efficiently.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      )<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"Conclusion\": \"KanBo enhances risk visibility, enabling proactive management of project delivery and performance challenges.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  )<\/p><p class=\"tekst-para-maly wp-block-paragraph\">)<\/p><p class=\"tekst-para-maly wp-block-paragraph\">```<\/p><h3 class=\"wp-block-heading naglowek-start compact-nag\">Additional Resources<\/h3><h3 class=\"wp-block-heading has-text-align-left prawy-tytul compact-nag\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Work Coordination Platform&nbsp;<\/h3><p class=\"has-text-align-left prawy-tekst compact-nag wp-block-paragraph\" style=\"margin-bottom:8px\">The KanBo Platform boosts efficiency and optimizes work management. Whether you need remote, onsite, or hybrid work capabilities, KanBo offers flexible installation options that give you control over your work environment.<\/p><p class=\"prawy-link compact-nag has-text-color has-link-color wp-elements-f81cac751942179cffc5595ea3093d69 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:24px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/kanboapp.com\/en\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Homepage \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul compact-nag\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Getting Started with KanBo<\/h3><p class=\"has-text-align-left prawy-tekst compact-nag wp-block-paragraph\" style=\"margin-bottom:8px\">Explore KanBo Learn, your go-to destination for tutorials and educational guides, offering expert insights and step-by-step instructions to optimize.<\/p><p class=\"prawy-link compact-nag has-text-color has-link-color wp-elements-80007a93c5109043d5274205e4d68368 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:24px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/learn.kanboapp.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Learn Platform \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul compact-nag\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">DevOps Help<\/h3><p class=\"has-text-align-left prawy-tekst compact-nag wp-block-paragraph\" style=\"margin-bottom:8px\">Explore Kanbo's DevOps guide to discover essential strategies for optimizing collaboration, automating processes, and improving team efficiency.<\/p><p class=\"prawy-link compact-nag has-text-color has-link-color wp-elements-23fbce8bb46a861d3991ae1a29f1d971 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:0px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/help.kanboapp.com\/en\/devops\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Dev Portal \u2192<\/a><\/p><\/div><\/div><\/div><\/div><\/div><\/div><div class=\"wp-block-column pasek-prawy spis2 jazda-nowsza is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-995f960e wp-block-columns-is-layout-flex\"><div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"padding-right:16px;padding-left:16px\"><h3 class=\"wp-block-heading has-text-align-left prawy-tytul-pulpit\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Work Coordination Platform&nbsp;<\/h3><p class=\"has-text-align-left prawy-tekst wp-block-paragraph\" style=\"margin-bottom:8px\">The KanBo Platform boosts efficiency and optimizes work management. Whether you need remote, onsite, or hybrid work capabilities, KanBo offers flexible installation options that give you control over your work environment.<\/p><p class=\"prawy-link has-text-color has-link-color wp-elements-40115c86dc2fe150fd9b1ed5dc10196e wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:32px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/kanboapp.com\/en\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Homepage \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul-pulpit\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Getting Started with KanBo<\/h3><p class=\"has-text-align-left prawy-tekst wp-block-paragraph\" style=\"margin-bottom:8px\">Explore KanBo Learn, your go-to destination for tutorials and educational guides, offering expert insights and step-by-step instructions to optimize.<\/p><p class=\"prawy-link has-text-color has-link-color wp-elements-02abac7c05b8b530fd3b1b7827aca587 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:32px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/learn.kanboapp.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Learn Platform \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul-pulpit\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">DevOps Help<\/h3><p class=\"has-text-align-left prawy-tekst wp-block-paragraph\" style=\"margin-bottom:8px\">Explore Kanbo's DevOps guide to discover essential strategies for optimizing collaboration, automating processes, and improving team efficiency.<\/p><p class=\"prawy-link has-text-color has-link-color wp-elements-09306734556c91c46ae8064a30b664b3 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:32px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/help.kanboapp.com\/en\/devops\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Dev Portal \u2192<\/a><\/p><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":3013,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-71441","page","type-page","status-publish","hentry"],"blocksy_meta":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\r\n<title>Enhancing Risk Visibility: Navigating Critical Challenges and Unleashing New Opportunities for SUSM in the Pharmaceutical Sector - KanBo<\/title>\r\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\r\n<link rel=\"canonical\" href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/\" \/>\r\n<meta property=\"og:locale\" content=\"en_US\" \/>\r\n<meta property=\"og:type\" content=\"article\" \/>\r\n<meta property=\"og:title\" content=\"Enhancing Risk Visibility: Navigating Critical Challenges and Unleashing New Opportunities for SUSM in the Pharmaceutical Sector - KanBo\" \/>\r\n<meta property=\"og:url\" content=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/\" \/>\r\n<meta property=\"og:site_name\" content=\"KanBo\" \/>\r\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"17 minutes\" \/>\r\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\\\/\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\\\/\",\"name\":\"Enhancing Risk Visibility: Navigating Critical Challenges and Unleashing New Opportunities for SUSM in the Pharmaceutical Sector - KanBo\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#website\"},\"datePublished\":\"2025-09-18T10:21:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Industries\",\"item\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"KanBo for Pharmaceutical\",\"item\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Enhancing Risk Visibility: Navigating Critical Challenges and Unleashing New Opportunities for SUSM in the Pharmaceutical Sector\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/\",\"name\":\"KanBo\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#organization\",\"name\":\"KanBo\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/image-122.png\",\"contentUrl\":\"https:\\\/\\\/kanboapp.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/image-122.png\",\"width\":196,\"height\":52,\"caption\":\"KanBo\"},\"image\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\r\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Enhancing Risk Visibility: Navigating Critical Challenges and Unleashing New Opportunities for SUSM in the Pharmaceutical Sector - KanBo","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/","og_locale":"en_US","og_type":"article","og_title":"Enhancing Risk Visibility: Navigating Critical Challenges and Unleashing New Opportunities for SUSM in the Pharmaceutical Sector - KanBo","og_url":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/","og_site_name":"KanBo","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"17 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/","url":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/","name":"Enhancing Risk Visibility: Navigating Critical Challenges and Unleashing New Opportunities for SUSM in the Pharmaceutical Sector - KanBo","isPartOf":{"@id":"https:\/\/kanboapp.com\/en\/#website"},"datePublished":"2025-09-18T10:21:23+00:00","breadcrumb":{"@id":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-navigating-critical-challenges-and-unleashing-new-opportunities-for-susm-in-the-pharmaceutical-sector\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/kanboapp.com\/en\/"},{"@type":"ListItem","position":2,"name":"Industries","item":"https:\/\/kanboapp.com\/en\/industries\/"},{"@type":"ListItem","position":3,"name":"KanBo for Pharmaceutical","item":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/"},{"@type":"ListItem","position":4,"name":"Enhancing Risk Visibility: Navigating Critical Challenges and Unleashing New Opportunities for SUSM in the Pharmaceutical Sector"}]},{"@type":"WebSite","@id":"https:\/\/kanboapp.com\/en\/#website","url":"https:\/\/kanboapp.com\/en\/","name":"KanBo","description":"","publisher":{"@id":"https:\/\/kanboapp.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kanboapp.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/kanboapp.com\/en\/#organization","name":"KanBo","url":"https:\/\/kanboapp.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/kanboapp.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/kanboapp.com\/wp-content\/uploads\/2023\/04\/image-122.png","contentUrl":"https:\/\/kanboapp.com\/wp-content\/uploads\/2023\/04\/image-122.png","width":196,"height":52,"caption":"KanBo"},"image":{"@id":"https:\/\/kanboapp.com\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages\/71441","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/comments?post=71441"}],"version-history":[{"count":0,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages\/71441\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages\/3013"}],"wp:attachment":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/media?parent=71441"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}